Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Genetic and environmental effects in paroxysmal nocturnal hemoglobinuria: this little PIG-A goes “Why? Why? Why?”
Neal S. Young, Jaroslaw P. Maciejewski
Neal S. Young, Jaroslaw P. Maciejewski
Published September 1, 2000
Citation Information: J Clin Invest. 2000;106(5):637-641. https://doi.org/10.1172/JCI11002.
View: Text | PDF
Commentary

Genetic and environmental effects in paroxysmal nocturnal hemoglobinuria: this little PIG-A goes “Why? Why? Why?”

  • Text
  • PDF
Abstract

Authors

Neal S. Young, Jaroslaw P. Maciejewski

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Models for clonal expansion in PNH. (a) In the first model, the PIG-A mu...
Models for clonal expansion in PNH. (a) In the first model, the PIG-A mutation sufficiently affects cellular function to cause an intrinsic growth advantage. (b) Extrinsic factors are invoked for other models; immune effects are illustrated, but differential responses to hematopoietic growth factors, inhibitory cytokines, or stromal cells are also possible. (c) GPI-anchor deficiency might produce a global deficit in immune recognition, as for example through absence of a costimulatory molecule on the target, providing a general selective advantage to the mutated cells. (d) Alternatively, a GPI-anchor protein might be antigenic, by resemblance to an exogenous antigen or after antigenic spread. (e) Finally, altered protein processing due to the absence of anchor structures might change the nature and quantity of peptides derived from normally GPI-anchored proteins, as well as their MHC presentation. As illustrated, cell surface proteins are normally recycled to the membrane or degraded by lysosomes for class II presentation; in PNH, anchorless proteins likely are processed by the proteasome for class I presentation. Differences in immune response to normal and PNH cells should follow.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts